FDA 510(k) cleared, CLIA waived
Strep A is responsible for over 600 million cases of pharyngitis annually. On a global scale, Group A Streptococcus (group A strep) is an important cause of morbidity and mortality.1 The infection presents similar symptoms to other illnesses in the early stages, so providing patients with the correct diagnosis earlier can help prevent complications or the unnecessary use of antibiotics.
A real-time polymerase chain reaction (PCR) test for the detection of Strep A in throat swab specimens from patients with signs and symptoms of pharyngitis, cobas® Liat® Strep A delivers labquality results in ~15 minutes.
Help patients get the treatment and relief they need faster with the reliable accuracy of the cobas® Liat® Strep A Test.2
FDA 510(k) cleared, CLIA waived
References
1. Carapetis JR, Steer AC, Mulholland EK, Weber, M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005:5(11);685-694.
2. cobas® Liat® Strep A [package insert]. Roche Molecular Systems, Inc.
The cobas® Liat® System is a fast, easy-to-use, compact PCR system designed for on-demand testing in point-of-care* settings such as physician clinics, pharmacy, and...